Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tubulin-tyrosine ligase activity	TTLL12 TTL	5.83e-05	2	153	2	GO:0004835
GeneOntologyBiologicalProcess	protein autophosphorylation	NRG1 ATR PDGFA CAMK2A CAMK2G INSRR NBN MTOR TAF1 FGFR4	7.20e-06	228	151	10	GO:0046777
GeneOntologyCellularComponent	intracellular protein-containing complex	UBR1 POLR1A CAMK2A MAT1A CAMK2G PSMA3 MARCHF6 PSMC2 POLA2 KLHL20 NCBP3 FBH1 MTOR FBXO31 WDR41 TAF1 TAF2 POTEJ TAF6 TAF1L BTRC TRAPPC9	2.43e-06	972	153	22	GO:0140535
GeneOntologyCellularComponent	PML body	CASP8AP2 ATR NBN KLHL20 PIAS4 MTOR RPA1	3.80e-05	125	153	7	GO:0016605
GeneOntologyCellularComponent	COPI vesicle coat	COPA COPG1 COPG2	1.04e-04	13	153	3	GO:0030126
GeneOntologyCellularComponent	nuclear DNA-directed RNA polymerase complex	POLR1A POLA2 TAF1 TAF2 TAF6 TAF1L	1.85e-04	113	153	6	GO:0055029
GeneOntologyCellularComponent	DNA-directed RNA polymerase complex	POLR1A POLA2 TAF1 TAF2 TAF6 TAF1L	2.13e-04	116	153	6	GO:0000428
GeneOntologyCellularComponent	RNA polymerase complex	POLR1A POLA2 TAF1 TAF2 TAF6 TAF1L	2.45e-04	119	153	6	GO:0030880
GeneOntologyCellularComponent	transferase complex	UBR1 POLR1A MAT1A MARCHF6 INSRR POLA2 KLHL20 PIAS4 FBH1 FBXO31 ALG14 WDR41 TAF1 TAF2 POTEJ TAF6 TAF1L BTRC	2.46e-04	963	153	18	GO:1990234
GeneOntologyCellularComponent	COPI-coated vesicle membrane	COPA COPG1 COPG2	3.42e-04	19	153	3	GO:0030663
GeneOntologyCellularComponent	transcription factor TFIID complex	TAF1 TAF2 TAF6 TAF1L	3.85e-04	47	153	4	GO:0005669
GeneOntologyCellularComponent	calcium- and calmodulin-dependent protein kinase complex	CAMK2A CAMK2G	5.25e-04	5	153	2	GO:0005954
GeneOntologyCellularComponent	nuclear chromosome	ARID4B INO80 POLA2 ORC5 LRPPRC SUV39H1 RPA1 TOP2A	5.79e-04	254	153	8	GO:0000228
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	COPA COPG1 OR5D18 VPS13C CAMK2G TPTE2 CYP26A1 MARCHF6 AGPAT3 POR COPG2 HHATL NBAS KSR1 LRPPRC UBA1 GUCY2C MTOR ALG14 SLC22A3 CYP26C1	6.88e-04	1327	153	21	GO:0042175
GeneOntologyCellularComponent	transferase complex, transferring phosphorus-containing groups	POLR1A INSRR POLA2 ALG14 WDR41 TAF1 TAF2 TAF6 TAF1L	8.29e-04	335	153	9	GO:0061695
GeneOntologyCellularComponent	Golgi-associated vesicle membrane	SYNRG COPA COPG1 COPG2	1.04e-03	61	153	4	GO:0030660
GeneOntologyCellularComponent	vesicle coat	SYNRG COPA COPG1 COPG2	1.48e-03	67	153	4	GO:0030120
GeneOntologyCellularComponent	MLL1 complex	TAF1 TAF6 TAF1L	1.63e-03	32	153	3	GO:0071339
GeneOntologyCellularComponent	COPI-coated vesicle	COPA COPG1 COPG2	1.79e-03	33	153	3	GO:0030137
GeneOntologyCellularComponent	MLL1/2 complex	TAF1 TAF6 TAF1L	1.79e-03	33	153	3	GO:0044665
Domain	TFIID_sub1_DUF3591	TAF1 TAF1L	6.41e-05	2	150	2	IPR022591
Domain	Coatomer_g_Cpla	COPG1 COPG2	6.41e-05	2	150	2	IPR032154
Domain	TBP-binding	TAF1 TAF1L	6.41e-05	2	150	2	PF09247
Domain	-	COPG1 COPG2	6.41e-05	2	150	2	2.60.40.1480
Domain	DUF3591	TAF1 TAF1L	6.41e-05	2	150	2	PF12157
Domain	COP-gamma_platf	COPG1 COPG2	6.41e-05	2	150	2	PF08752
Domain	Coatomer_g_Cpla	COPG1 COPG2	6.41e-05	2	150	2	PF16381
Domain	Coatomer_gsu_app_Ig-like-sub	COPG1 COPG2	6.41e-05	2	150	2	IPR013040
Domain	TAF_II_230-bd	TAF1 TAF1L	6.41e-05	2	150	2	IPR009067
Domain	-	TAF1 TAF1L	6.41e-05	2	150	2	1.10.1100.10
Domain	Coatomer_gsu	COPG1 COPG2	6.41e-05	2	150	2	IPR017106
Domain	TAF1_animal	TAF1 TAF1L	6.41e-05	2	150	2	IPR011177
Domain	Neuregulin_C	NRG1 NRG2	1.91e-04	3	150	2	IPR002154
Domain	Neuregulin	NRG1 NRG2	1.91e-04	3	150	2	PF02158
Domain	F-box_dom	FBXW10B FBXW10 FBH1 FBXO31 BTRC	3.43e-04	75	150	5	IPR001810
Domain	-	FBXW10B FBXW10 WDR64 COPA CFAP43 NBAS ZNF106 WDR41 BTRC PLXNA1	3.66e-04	333	150	10	2.130.10.10
Domain	CaMKII_AD	CAMK2A CAMK2G	3.80e-04	4	150	2	PF08332
Domain	Clathrin_a/coatomer_app_sub_C	COPG1 COPG2	3.80e-04	4	150	2	IPR015873
Domain	Ca/CaM-dep_prot_kinase-assoc	CAMK2A CAMK2G	3.80e-04	4	150	2	IPR013543
Domain	-	COPG1 COPG2	3.80e-04	4	150	2	3.30.310.30
Domain	WD40/YVTN_repeat-like_dom	FBXW10B FBXW10 WDR64 COPA CFAP43 NBAS ZNF106 WDR41 BTRC PLXNA1	3.84e-04	335	150	10	IPR015943
Domain	WD_REPEATS_1	FBXW10B FBXW10 WDR64 COPA CFAP43 NBAS ZNF106 WDR41 BTRC	4.20e-04	278	150	9	PS00678
Domain	WD_REPEATS_2	FBXW10B FBXW10 WDR64 COPA CFAP43 NBAS ZNF106 WDR41 BTRC	4.31e-04	279	150	9	PS50082
Domain	WD_REPEATS_REGION	FBXW10B FBXW10 WDR64 COPA CFAP43 NBAS ZNF106 WDR41 BTRC	4.31e-04	279	150	9	PS50294
Domain	Kinase-like_dom	TRPM6 ATR CAMK2A CAMK2G INSRR ARHGAP35 STK31 KSR1 GUCY2C MTOR MACF1 FGFR4 PKN3	4.38e-04	542	150	13	IPR011009
Domain	G-protein_beta_WD-40_rep	FBXW10B FBXW10 COPA WDR41 BTRC	6.12e-04	85	150	5	IPR020472
Domain	FATC	ATR MTOR	6.31e-04	5	150	2	PF02260
Domain	FF_domain	ARHGAP35 TCERG1	9.41e-04	6	150	2	IPR002713
Domain	FF	ARHGAP35 TCERG1	9.41e-04	6	150	2	PS51676
Domain	FF	ARHGAP35 TCERG1	9.41e-04	6	150	2	PF01846
Domain	FF	ARHGAP35 TCERG1	9.41e-04	6	150	2	SM00441
Domain	FAT	ATR MTOR	9.41e-04	6	150	2	PS51189
Domain	FATC	ATR MTOR	9.41e-04	6	150	2	PS51190
Domain	FAT	ATR MTOR	9.41e-04	6	150	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR MTOR	9.41e-04	6	150	2	IPR003151
Domain	FATC_dom	ATR MTOR	9.41e-04	6	150	2	IPR003152
Domain	PIK_FAT	ATR MTOR	9.41e-04	6	150	2	IPR014009
Domain	FATC	ATR MTOR	9.41e-04	6	150	2	SM01343
Domain	-	TDRD9 ERCC6L PSMC2 INO80 ARHGAP35 IFIH1 ORC5 CTPS2 MDN1 GIMAP8 FBH1 RAB39A DDX60L CHST2 CHST7	9.98e-04	746	150	15	3.40.50.300
Domain	TUDOR	ARID4B TDRD9 STK31	1.29e-03	27	150	3	SM00333
Domain	Carbohydrate_sulfotransferase	CHST2 CHST7	1.31e-03	7	150	2	IPR016469
Domain	P-loop_NTPase	TDRD9 ERCC6L MYO9B PSMC2 INO80 ARHGAP35 IFIH1 ORC5 CTPS2 MDN1 GIMAP8 FBH1 RAB39A DDX60L CHST2 CHST7	1.32e-03	848	150	16	IPR027417
Domain	WD40	FBXW10B FBXW10 WDR64 COPA CFAP43 ZNF106 WDR41 BTRC	1.48e-03	268	150	8	SM00320
Domain	WD40_repeat	FBXW10B FBXW10 WDR64 COPA CFAP43 ZNF106 WDR41 BTRC	1.62e-03	272	150	8	IPR001680
Domain	Helicase_C	TDRD9 ERCC6L INO80 IFIH1 DDX60L	1.72e-03	107	150	5	PF00271
Domain	HELICc	TDRD9 ERCC6L INO80 IFIH1 DDX60L	1.72e-03	107	150	5	SM00490
Domain	DUF1669	FAM83F FAM83D	1.74e-03	8	150	2	PF07894
Domain	DUF1669	FAM83F FAM83D	1.74e-03	8	150	2	IPR012461
Domain	Coatomer/calthrin_app_sub_C	COPG1 COPG2	1.74e-03	8	150	2	IPR009028
Domain	Tudor	ARID4B TDRD9 STK31	1.76e-03	30	150	3	IPR002999
Domain	Helicase_C	TDRD9 ERCC6L INO80 IFIH1 DDX60L	1.79e-03	108	150	5	IPR001650
Domain	HELICASE_CTER	TDRD9 ERCC6L INO80 IFIH1 DDX60L	1.87e-03	109	150	5	PS51194
Domain	HELICASE_ATP_BIND_1	TDRD9 ERCC6L INO80 IFIH1 DDX60L	1.87e-03	109	150	5	PS51192
Domain	DEXDc	TDRD9 ERCC6L INO80 IFIH1 DDX60L	1.87e-03	109	150	5	SM00487
Domain	Helicase_ATP-bd	TDRD9 ERCC6L INO80 IFIH1 DDX60L	1.95e-03	110	150	5	IPR014001
Domain	HEAT_REPEAT	ATR COPG1 COPG2 MTOR	2.43e-03	70	150	4	PS50077
Pathway	REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS	PIK3AP1 NRG1 SPRED2 HDAC4 PDGFA CAMK2A CAMK2G PSMA3 PSMC2 NRG2 KSR1 HEYL MTOR MIB1 FGFR4 VCL	1.10e-06	464	115	16	M27547
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION	ATR NBN TAF1 TAF2 TAF6 RPA1 TAF1L	9.90e-06	92	115	7	M27636
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	NRG1 SPRED2 PDGFA CAMK2A CAMK2G PSMA3 PSMC2 NRG2 KSR1 PTPRA FGFR4 VCL	1.44e-05	327	115	12	M27565
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	GPLD1 CASP8AP2 USP18 FBXW10 HDAC4 COPA COPG1 PSMA3 MARCHF6 PSMC2 COPG2 B3GNT7 INO80 KLHL20 TTLL12 PIAS4 IFIH1 UBA1 IGFBP1 FBXO31 ALG14 TTL ADAMTS20 RAB39A RPA1 BTRC TRAPPC9 TOP2A	1.49e-05	1475	115	28	M19806
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	GPLD1 CASP8AP2 USP18 FBXW10B FBXW10 HDAC4 COPA COPG1 PSMA3 PSMC2 COPG2 B3GNT7 INO80 KLHL20 TTLL12 PIAS4 IFIH1 UBA1 IGFBP1 FBXO31 ALG14 ADAMTS20 RAB39A RPA1 TRAPPC9 TOP2A	4.15e-05	1389	115	26	MM15307
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY	ATR NBN MTOR TAF1 TAF2 TAF6 RPA1 TAF1L	4.89e-05	160	115	8	M27498
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	NRG1 SPRED2 PDGFA CAMK2A CAMK2G PSMA3 PSMC2 KSR1 PTPRA FGFR4 VCL	5.72e-05	318	115	11	MM15278
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION	NBN TAF1 TAF2 TAF6 RPA1 TAF1L	1.04e-04	92	115	6	MM15338
Pathway	KEGG_BASAL_TRANSCRIPTION_FACTORS	TAF1 TAF2 TAF6 TAF1L	1.81e-04	35	115	4	M4864
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	PIK3AP1 NRG1 PDGFA CAMK2A CAMK2G PSMA3 PSMC2 NRG2 MTOR FGFR4	2.40e-04	313	115	10	M27867
Pathway	REACTOME_PI3K_AKT_SIGNALING_IN_CANCER	PIK3AP1 NRG1 PDGFA NRG2 MTOR FGFR4	2.78e-04	110	115	6	M27162
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY	NBN MTOR TAF1 TAF2 TAF6 RPA1 TAF1L	2.98e-04	157	115	7	MM15226
Pathway	PID_IFNG_PATHWAY	CAMK2A CAMK2G PIAS4 MTOR	3.06e-04	40	115	4	M161
Pathway	KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY	PDGFA CAMK2A CAMK2G	3.31e-04	17	115	3	M47387
Pathway	REACTOME_G2_M_CHECKPOINTS	ATR PSMA3 PSMC2 NBN PIAS4 ORC5 RPA1	4.33e-04	167	115	7	M19381
Pathway	REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS	CAMK2A CAMK2G KSR1 VCL	4.84e-04	45	115	4	M27623
Pathway	WP_ERBB_SIGNALING_PATHWAY	NRG1 CAMK2A NRG2 MTOR	5.27e-04	46	115	4	MM15950
Pathway	REACTOME_ONCOGENIC_MAPK_SIGNALING	SPRED2 CAMK2A CAMK2G KSR1 VCL	5.48e-04	82	115	5	M27626
Pathway	WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE	HDAC4 ATR NBN MTOR	5.72e-04	47	115	4	M39518
Pathway	REACTOME_HIV_TRANSCRIPTION_INITIATION	TAF1 TAF2 TAF6 TAF1L	5.72e-04	47	115	4	M29568
Pathway	PID_FANCONI_PATHWAY	ATR NBN FANCB RPA1	5.72e-04	47	115	4	M1
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER	PIK3AP1 NRG1 PDGFA NRG2 FGFR4	5.79e-04	83	115	5	M27163
Pathway	REACTOME_HIV_INFECTION	DOCK2 PSMA3 PSMC2 TAF1 TAF2 TAF6 TAF1L BTRC	6.05e-04	231	115	8	M12469
Pathway	REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE	TAF1 TAF2 TAF6 TAF1L	6.20e-04	48	115	4	MM15424
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY	NRG1 NRG2	6.49e-04	5	115	2	M48991
Pathway	REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING	NRG1 NRG2	6.49e-04	5	115	2	M26937
Pathway	REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	COPA COPG1 AGPAT3 COPG2 BICD1 NBAS	7.06e-04	131	115	6	MM15497
Pathway	KEGG_ERBB_SIGNALING_PATHWAY	NRG1 CAMK2A CAMK2G NRG2 MTOR	7.18e-04	87	115	5	M12467
Pathway	REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	COPA COPG1 AGPAT3 COPG2 BICD1 NBAS	7.95e-04	134	115	6	M27751
Pathway	KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION	COPA COPG1 COPG2	8.31e-04	23	115	3	M47772
Pathway	REACTOME_LONG_TERM_POTENTIATION	NRG1 CAMK2A CAMK2G	8.31e-04	23	115	3	M27949
Pathway	REACTOME_HSF1_DEPENDENT_TRANSACTIVATION	CAMK2A CAMK2G MTOR	8.31e-04	23	115	3	MM14953
Pathway	REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC	COPA COPG1 AGPAT3 COPG2 BICD1 NBAS RAB39A	9.03e-04	189	115	7	MM15356
Pathway	WP_ERBB_SIGNALING	NRG1 CAMK2A CAMK2G NRG2 MTOR	9.26e-04	92	115	5	M39715
Pathway	REACTOME_VITAMINS	CYP26A1 CYP26C1	9.69e-04	6	115	2	M27125
Pathway	REACTOME_VITAMINS	CYP26A1 CYP26C1	9.69e-04	6	115	2	MM14840
Pathway	REACTOME_G2_M_CHECKPOINTS	PSMA3 PSMC2 NBN PIAS4 ORC5 RPA1	1.12e-03	143	115	6	MM15383
Pathway	REACTOME_DNA_REPLICATION_PRE_INITIATION	PSMA3 PSMC2 POLA2 ORC5 RPA1	1.17e-03	97	115	5	MM15369
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TRPM6 SOX9 USP18 FBXW10B FBXW10 KLHL28 ATP8A2 CAMK2G TPTE2 KLHL20 EIF3CL PTP4A1 PIAS4 UBA1 PTPRA SUV39H1 TAF1 TAF1L PLXNA1	7.81e-10	730	155	19	34857952
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UBR1 SYNRG ARID4B ATR COPA ERCC6L PSMA3 NBN ARHGAP35 POLA2 EXOSC2 EIF3CL ZNF106 UBA1 MDN1 SVIL TAF6 TOP2A ARHGEF6	2.04e-09	774	155	19	15302935
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SYNRG HDAC4 ERCC6L CAMK2A TTLL12 KSR1 ZNF106 LRPPRC C2CD3 MDN1 TCERG1 SYNJ2 MTOR SYDE2 SVIL MACF1 TRAPPC9 EDRF1	6.39e-08	861	155	18	36931259
Pubmed	NBS1 mediates ATR-dependent RPA hyperphosphorylation following replication-fork stall and collapse.	ATR NBN RPA1	8.68e-08	3	155	3	18003706
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	SOX9 CASP8AP2 POLR1A ATR COPA PSMA3 NBN INO80 POLA2 EXOSC2 UBA1 MDN1 TCERG1 CPNE1 TAF1 TAF2 TAF6 RPA1 TOP2A	1.47e-07	1014	155	19	32416067
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UBR1 POLR1A COPA COPG1 MYO9B CAMK2G PSMA3 PSMC2 LRPPRC UBA1 MDN1 TCERG1 MIB1 SNX27 MACF1 DDX60L TAF2 RPA1 CAPRIN1 BTRC TOP2A VCL	1.65e-07	1353	155	22	29467282
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SYNRG POLR1A COPA COPG1 CAMK2G NBN INO80 ARHGAP35 EXOSC2 UBA1 SYNJ2 FAM83D MACF1 TAF2 CAPRIN1 VCL	1.72e-07	724	155	16	36232890
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PIK3AP1 SYNRG VPS13C PSMC2 NBN EXOSC2 BICD1 C2CD3 SYNJ2 SLC25A15 SVIL MIB1 TAF2 RINL NEURL4 TOP2A VCL	2.97e-07	853	155	17	28718761
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DOCK2 NRG1 ATR COPA COPG1 ERCC6L PSMC2 NBN COPG2 ORC5 MDN1 MACF1 RPA1 TOP2A	3.86e-07	582	155	14	20467437
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 POLR1A ATR COPA COPG1 VPS13C PSMA3 POR MRPS35 EIF3CL TTLL12 LRPPRC UBA1 MDN1 TCERG1 MTOR CHST2 RPA1 CAPRIN1 PLXNA1 TOP2A VCL	3.97e-07	1425	155	22	30948266
Pubmed	The TBN protein, which is essential for early embryonic mouse development, is an inducible TAFII implicated in adipogenesis.	TAF1 TAF2 TAF6 TAF1L	4.99e-07	15	155	4	14580349
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	COPA COPG1 CAMK2G PSMA3 PSMC2 MRPS35 COPG2 EXOSC2 EIF3CL TTLL12 LRPPRC UBA1 MDN1 TCERG1 SVIL MACF1 RPA1 CAPRIN1 VCL	9.67e-07	1149	155	19	35446349
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	COPA COPG1 ERCC6L MRPS35 EIF3CL TTLL12 ORC5 NBAS FANCB ZNF106 UBA1 SYNJ2 SVIL MIB1 FAM83D CAPRIN1 NEURL4 TOP2A VCL	1.04e-06	1155	155	19	20360068
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FAT4 WDR64 ARID4B ERCC6L CAMK2G MRPS35 NBN STK31 MDN1 TMTC3 UNC5C MIB1 TAF2 POTEJ	1.15e-06	638	155	14	31182584
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	COPA COPG1 PSMC2 NBN COPG2 POLA2 ORC5 LRPPRC TCERG1 GLG1 RAB39A WDR41 TOP2A	1.52e-06	560	155	13	35241646
Pubmed	Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation.	TAF1 TAF2 TAF6	1.72e-06	6	155	3	7680771
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	HDAC4 CAMK2A AGPAT3 MRPS35 EXOSC2 EIF3CL FANCB KSR1 LRPPRC UBA1 MTOR SNX27 RAB39A RPA1 NEURL4 TRAPPC9 EDRF1 ARHGEF6 PKN3 VCL	1.90e-06	1321	155	20	27173435
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	COPA COPG1 TTLL12 PIAS4 UBA1 MDN1 TCERG1 SNX27 TAF1 TOP2A	2.65e-06	332	155	10	32786267
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	NRG1 ERCC6L PSMC2 POR MRPS35 COL25A1 ARHGAP35 KSR1 MDN1 SVIL INTS15 MIB1 TAF2 TAF1L	2.80e-06	689	155	14	36543142
Pubmed	Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation.	TAF1 TAF2 TAF6	3.00e-06	7	155	3	7597030
Pubmed	The Mre11-Rad50-Nbs1 complex acts both upstream and downstream of ataxia telangiectasia mutated and Rad3-related protein (ATR) to regulate the S-phase checkpoint following UV treatment.	ATR NBN RPA1	3.00e-06	7	155	3	17526493
Pubmed	BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.	ATR NBN RPA1	3.00e-06	7	155	3	16872911
Pubmed	HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration.	UBR1 UBA1 FBXO31 MIB1 CAPRIN1 BTRC	3.25e-06	90	155	6	35671810
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	SOX9 ARID4B INO80 POLA2 EXOSC2 NCBP3 PIAS4 ORC5 SUV39H1 TAF1 TAF2 RPA1 TOP2A	3.72e-06	608	155	13	36089195
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ATR COPA MYO9B NBAS TMTC3 MTOR CAPRIN1 NEURL4	3.74e-06	202	155	8	33005030
Pubmed	Evolutionarily conserved regulators of tau identify targets for new therapies.	COPA COPG1 PSMA3 MARCHF6 PSMC2 POR PTP4A1 GLG1 RAB39A FGFR4 PLXNA1 VCL	3.82e-06	516	155	12	36610398
Pubmed	Novel isotypic gamma/zeta subunits reveal three coatomer complexes in mammals.	COPA COPG1 COPG2	4.78e-06	8	155	3	14729954
Pubmed	In vivo assembly of coatomer, the COP-I coat precursor.	COPA COPG1 COPG2	4.78e-06	8	155	3	8940050
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	COPA TPTE2 PSMC2 POR NBN COPG2 PTPRT PTP4A1 UBA1 C2CD3 PTPRA SVIL MIB1 SNX27 RPA1 NEURL4 BTRC	4.89e-06	1049	155	17	27880917
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SYNRG ERCC6L NBN PIAS4 ZNF106 UBA1 TCERG1 TAF6 RPA1 CAPRIN1 TOP2A	5.41e-06	444	155	11	34795231
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	COPA COPG1 ERCC6L PSMA3 PSMC2 COPG2 TTLL12 LRPPRC UBA1 MDN1 TCERG1 MTOR RPA1	6.24e-06	638	155	13	33239621
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SYNRG ERCC6L PSMC2 NBN ARHGAP35 UBA1 TCERG1 TAF1 TAF2 TAF6 TOP2A VCL	7.14e-06	549	155	12	38280479
Pubmed	The intracellular localisation of TAF7L, a paralogue of transcription factor TFIID subunit TAF7, is developmentally regulated during male germ-cell differentiation.	TAF1 TAF6 TAF1L	7.15e-06	9	155	3	12665565
Pubmed	A single binding site for dilysine retrieval motifs and p23 within the gamma subunit of coatomer.	COPA COPG1 COPG2	7.15e-06	9	155	3	9751720
Pubmed	COP I domains required for coatomer integrity, and novel interactions with ARF and ARF-GAP.	COPA COPG1 COPG2	7.15e-06	9	155	3	10921873
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	COPA COPG1 PSMA3 PSMC2 COPG2 LRPPRC UBA1 MDN1 MTOR SNX27 CPNE1 TOP2A VCL	7.25e-06	647	155	13	26618866
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	POLR1A COPA COPG1 PSMC2 COPG2 TTF1 TTLL12 LRPPRC MDN1 MTOR MACF1 CAPRIN1 VCL	8.00e-06	653	155	13	22586326
Pubmed	Acquisition of cellular properties during alveolar formation requires differential activity and distribution of mitochondria.	SOX9 PDGFA LRPPRC	1.02e-05	10	155	3	35384838
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	POLR1A NBN INO80 LRPPRC UBA1 MDN1 TAF1 TAF6 RPA1 TOP2A	1.19e-05	394	155	10	27248496
Pubmed	GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles.	COPA COPG1 COPG2 GLG1	1.24e-05	32	155	4	34473204
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	POLR1A COPA COPG1 PSMC2 MRPS35 COPG2 NBAS CTPS2 MTOR SUV39H1 SNX27 RPA1 TOP2A	1.77e-05	704	155	13	29955894
Pubmed	Correction: RDH10-mediated retinol metabolism and RARα-mediated retinoic acid signaling are required for submandibular salivary gland initiation (doi: 10.1242/dev.164822).	SOX9 CYP26A1 CYP26C1	1.85e-05	12	155	3	30166332
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	PIK3AP1 MAT1A CAMK2G CFAP43 ADAM8 FBH1 SVIL CYP26C1 BTRC VCL	1.85e-05	415	155	10	16385451
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	COPA COPG1 EXOSC2 GLG1 MIB1 RPA1 CAPRIN1	1.86e-05	182	155	7	31067453
Pubmed	SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.	SOX9 MTOR	1.97e-05	2	155	2	29550418
Pubmed	PlexinA1 deficiency in BALB/cAJ mice leads to excessive self-grooming and reduced prepulse inhibition.	GAD1 PLXNA1	1.97e-05	2	155	2	33163687
Pubmed	The ZATT-TOP2A-PICH Axis Drives Extensive Replication Fork Reversal to Promote Genome Stability.	ERCC6L TOP2A	1.97e-05	2	155	2	33296677
Pubmed	Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders.	TAF1 TAF1L	1.97e-05	2	155	2	38804708
Pubmed	ATR prohibits replication catastrophe by preventing global exhaustion of RPA.	ATR RPA1	1.97e-05	2	155	2	24267891
Pubmed	Sustained expression of a neuron-specific isoform of the Taf1 gene in development stages and aging in mice.	TAF1 TAF1L	1.97e-05	2	155	2	22842574
Pubmed	NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis.	NRG1 NRG2	1.97e-05	2	155	2	34996744
Pubmed	CaMKII is essential for the function of the enteric nervous system.	CAMK2A CAMK2G	1.97e-05	2	155	2	22952977
Pubmed	Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.	TAF1 TAF1L	1.97e-05	2	155	2	27571988
Pubmed	Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms.	TAF1 TAF1L	1.97e-05	2	155	2	34403156
Pubmed	Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).	GPLD1 MTOR	1.97e-05	2	155	2	24990952
Pubmed	Opposing HDAC4 nuclear fluxes due to phosphorylation by β-adrenergic activated protein kinase A or by activity or Epac activated CaMKII in skeletal muscle fibres.	HDAC4 CAMK2A	1.97e-05	2	155	2	23652597
Pubmed	BCAP links IL-1R to the PI3K-mTOR pathway and regulates pathogenic Th17 cell differentiation.	PIK3AP1 MTOR	1.97e-05	2	155	2	30093533
Pubmed	In vitro analysis of the role of replication protein A (RPA) and RPA phosphorylation in ATR-mediated checkpoint signaling.	ATR RPA1	1.97e-05	2	155	2	22948311
Pubmed	Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.	IGFBP1 MTOR	1.97e-05	2	155	2	26714229
Pubmed	Bioactive recombinant neuregulin-1, -2, and -3 expressed in Escherichia coli.	NRG1 NRG2	1.97e-05	2	155	2	15039062
Pubmed	Phylogenetic relationships of the seven coat protein subunits of the coatomer complex, and comparative sequence analysis of murine xenin and proxenin.	COPA COPG2	1.97e-05	2	155	2	11530856
Pubmed	FBXW10 promotes hepatocarcinogenesis in male patients and mice.	FBXW10B FBXW10	1.97e-05	2	155	2	31400758
Pubmed	PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis.	ERCC6L TOP2A	1.97e-05	2	155	2	26643143
Pubmed	Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.	ERCC6L TOP2A	1.97e-05	2	155	2	17956945
Pubmed	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.	FBXW10B FBXW10	1.97e-05	2	155	2	37450367
Pubmed	DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator.	TAF1 TAF2	1.97e-05	2	155	2	10469661
Pubmed	TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin.	TAF1 TAF1L	1.97e-05	2	155	2	10070062
Pubmed	NBS1 directly activates ATR independently of MRE11 and TOPBP1.	ATR NBN	1.97e-05	2	155	2	23368512
Pubmed	Nbs1 is required for ATR-dependent phosphorylation events.	ATR NBN	1.97e-05	2	155	2	15616588
Pubmed	RDH10-mediated retinol metabolism and RARα-mediated retinoic acid signaling are required for submandibular salivary gland initiation.	SOX9 CYP26A1 CYP26C1	2.40e-05	13	155	3	29986869
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	MYO9B INO80 EIF3CL PIAS4 MDN1 TCERG1 TAF1 TAF2 TAF6 NEURL4 TOP2A	2.94e-05	533	155	11	30554943
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	POLR1A COPA PSMA3 PSMC2 NBN COPG2 TTLL12 LRPPRC UBA1 SNX27 RPA1	2.99e-05	534	155	11	35032548
Pubmed	Structure of promoter-bound TFIID and model of human pre-initiation complex assembly.	TAF1 TAF2 TAF6	3.05e-05	14	155	3	27007846
Pubmed	FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress.	FBH1 FBXO31 RPA1	3.05e-05	14	155	3	23319600
Pubmed	Human TFIID binds to core promoter DNA in a reorganized structural state.	TAF1 TAF2 TAF6	3.05e-05	14	155	3	23332750
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	HDAC4 PSMA3 PTPRA MTOR UNC5C MIB1 MACF1 TAF1 TOP2A	3.53e-05	358	155	9	32460013
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CASP8AP2 POR MRPS35 NBN NCBP3 TTLL12 NBAS LRPPRC MDN1 TMTC3 GLG1 SLC25A15 MIB1 MACF1 WDR41 CAPRIN1 NEURL4 EDRF1 VCL	3.72e-05	1487	155	19	33957083
Pubmed	Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.	COPA COPG1 MYO9B COPG2 BICD1 NEURL4	3.92e-05	139	155	6	25476789
Pubmed	Dominant and redundant functions of TFIID involved in the regulation of hepatic genes.	IGFBP1 TAF1 TAF6 TAF1L	4.09e-05	43	155	4	18722179
Pubmed	Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly.	TAF1 TAF2 TAF6	4.66e-05	16	155	3	8764009
Pubmed	Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.	TAF1 TAF2 TAF6	4.66e-05	16	155	3	8680883
Pubmed	A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro.	TAF1 TAF2 TAF6	4.66e-05	16	155	3	7836461
Pubmed	Novel mechanism and factor for regulation by HIV-1 Tat.	TAF1 TAF2 TAF6	4.66e-05	16	155	3	7835343
Pubmed	Direct interaction of human TFIID with the HIV-1 transactivator tat.	TAF1 TAF2 TAF6	4.66e-05	16	155	3	8121496
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	USP18 POLR1A COPA COPG1 CAMK2G PSMC2 MRPS35 POLA2 KLHL20 LRPPRC CTPS2 SNX27 CPNE1 NEURL4 BTRC	4.67e-05	1005	155	15	19615732
Pubmed	Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.	COPG1 MYO9B PSMA3 PSMC2 COPG2 LRPPRC TOP2A	4.77e-05	211	155	7	17314511
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	POLR1A COPA COPG1 CAMK2G PSMA3 PSMC2 EXOSC2 EIF3CL ORC5 LRPPRC UBA1 CTPS2 MDN1 TCERG1 RAB39A WDR41 RPA1	4.90e-05	1257	155	17	37317656
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GAD1 SYNRG COPG1 CAMK2A CAMK2G PSMC2 POR MRPS35 ARHGAP35 EIF3CL LRPPRC UBA1 GLG1 MACF1 CAPRIN1 BTRC	5.31e-05	1139	155	16	36417873
Pubmed	TAF4, a subunit of transcription factor II D, directs promoter occupancy of nuclear receptor HNF4A during post-natal hepatocyte differentiation.	SOX9 TAF1 TAF6 TAF1L	5.35e-05	46	155	4	25209997
Pubmed	Placental Remote Control of Fetal Metabolism: Trophoblast mTOR Signaling Regulates Liver IGFBP-1 Phosphorylation and IGF-1 Bioavailability.	IGFBP1 MTOR	5.90e-05	3	155	2	37108437
Pubmed	Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.	ATR TOP2A	5.90e-05	3	155	2	25846551
Pubmed	CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair.	CAMK2A CAMK2G	5.90e-05	3	155	2	31481791
Pubmed	SOX9 promotes nasopharyngeal carcinoma cell proliferation, migration and invasion through BMP2 and mTOR signaling.	SOX9 MTOR	5.90e-05	3	155	2	31357026
Pubmed	Nonsyndromic bilateral and unilateral optic nerve aplasia: first familial occurrence and potential implication of CYP26A1 and CYP26C1 genes.	CYP26A1 CYP26C1	5.90e-05	3	155	2	21850183
Pubmed	CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses.	HDAC4 CAMK2A	5.90e-05	3	155	2	17923476
Pubmed	mTrs130 is a component of a mammalian TRAPPII complex, a Rab1 GEF that binds to COPI-coated vesicles.	COPG1 TRAPPC9	5.90e-05	3	155	2	19656848
Pubmed	Fluconazole alters CYP26 gene expression in mouse embryos.	CYP26A1 CYP26C1	5.90e-05	3	155	2	19429397
Pubmed	Deubiquitinase USP18 regulates reactive astrogliosis by stabilizing SOX9.	SOX9 USP18	5.90e-05	3	155	2	33694203
Pubmed	Transient expression of SOX9 protein during follicular development in the adult mouse ovary.	SOX9 POR	5.90e-05	3	155	2	16488195
Pubmed	Evidence for a functional genetic polymorphism of the human retinoic acid-metabolizing enzyme CYP26A1, an enzyme that may be involved in spina bifida.	CYP26A1 CYP26C1	5.90e-05	3	155	2	16933217
Interaction	HERC2 interactions	HDAC4 COPA COPG1 MYO9B PSMC2 COPG2 BICD1 PIAS4 SUV39H1 MACF1 TAF1 TAF2 RPA1 TAF1L NEURL4	4.63e-06	503	148	15	int:HERC2
Interaction	YWHAH interactions	SYNRG HDAC4 ERCC6L CAMK2G PSMC2 POLA2 IFIH1 KSR1 ZNF106 UBA1 C2CD3 TCERG1 SYNJ2 MTOR SYDE2 SVIL MACF1 RPA1 TRAPPC9 EDRF1 ARHGEF6 VCL	1.82e-05	1102	148	22	int:YWHAH
Interaction	GSK3B interactions	SOX9 UBR1 SYNRG HDAC4 COPG1 PRSS37 PSMC2 ARHGAP35 BICD1 TTLL12 UBA1 MTOR FAM83D MACF1 RPA1 CAPRIN1 BTRC TOP2A VCL	2.06e-05	868	148	19	int:GSK3B
Interaction	BCL2L1 interactions	UBR1 CASP8AP2 USP18 HDAC4 GNLY KLHL20 MTOR SVIL EDRF1	2.86e-05	213	148	9	int:BCL2L1
Interaction	NR3C1 interactions	UBR1 CASP8AP2 FAT4 WDR64 ARID4B ERCC6L CAMK2G POR MRPS35 NBN STK31 LRPPRC MDN1 TMTC3 SVIL UNC5C MIB1 TAF2 POTEJ RPA1	3.06e-05	974	148	20	int:NR3C1
Interaction	PPP5C interactions	GAD1 ATR CAMK2A CAMK2G PSMC2 UBA1 FAM83F CPNE1 RPA1 VCL	3.38e-05	272	148	10	int:PPP5C
Interaction	SCYL1 interactions	COPA COPG1 AGPAT3 COPG2 POLA2 MACF1 TAF6 RPA1	3.61e-05	169	148	8	int:SCYL1
Interaction	YWHAG interactions	SYNRG HDAC4 ERCC6L CAMK2G TTLL12 KSR1 ZNF106 UBA1 C2CD3 MDN1 TCERG1 SYNJ2 MTOR SYDE2 SVIL SNX27 MACF1 RPA1 BTRC TRAPPC9 EDRF1 ARHGEF6 VCL	4.04e-05	1248	148	23	int:YWHAG
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW10B FBXW10 BTRC	3.21e-05	11	107	3	559
GeneFamily	Cytochrome P450 family 26	CYP26A1 CYP26C1	1.04e-04	3	107	2	1013
GeneFamily	WD repeat domain containing	FBXW10B FBXW10 WDR64 COPA CFAP43 WDR41 BTRC	9.43e-04	262	107	7	362
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SOX9 NRG1 SPRED2 HDAC4 ATR MYO9B MARCHF6 NBN ARHGAP35 KLHL20 BICD1 ORC5 NBAS LRPPRC C2CD3 PTPRA MDN1 SYNJ2 MACF1 BTRC TOP2A VCL	6.52e-09	856	154	22	M4500
Coexpression	PEREZ_TP53_TARGETS	TRPM6 USP18 GAD1 KLHL28 POLR1A METRNL VPS13C CAMK2G AGPAT3 NRG2 B3GNT7 KLHL20 HHATL IFIH1 KSR1 EDAR FAM83F UMODL1 INTS15 FAM83D CHST2 ARHGEF6	2.19e-06	1201	154	22	M4391
Coexpression	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	PIAS4 C2CD3 CTPS2 IGFBP1 FBH1 FAM83F PRELID2 MTOR SUV39H1 MIB1 WDR41 CAPRIN1 PLXNA1 TOP2A ARHGEF6	6.68e-06	646	154	15	M2419
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	CASP8AP2 ATR MARCHF6 COL25A1 ORC5 EDAR SYDE2 ADAMTS20 TAF2 RPA1 CAPRIN1 TOP2A	1.05e-05	434	154	12	M15150
Coexpression	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	PIAS4 C2CD3 CTPS2 IGFBP1 FBH1 FAM83F PRELID2 MTOR SUV39H1 MIB1 WDR41 CAPRIN1 PLXNA1 TOP2A ARHGEF6	1.12e-05	675	154	15	MM1073
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	CASP8AP2 ATR MARCHF6 COL25A1 ORC5 EDAR SYDE2 ADAMTS20 TAF2 RPA1 CAPRIN1 TOP2A	1.44e-05	448	154	12	MM1044
Coexpression	GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	DOCK2 SPRED2 INSRR NBN PTPRT IFIH1 PTPRA BTRC	2.43e-05	199	154	8	M7756
Coexpression	GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN	GAD1 CAMK2A CFAP43 KSR1 PRELID2 SVIL KBTBD12 PLXNA1	2.52e-05	200	154	8	M6789
Coexpression	BARIS_THYROID_CANCER_DN	UBA1 GLG1 FGFR4 PKN3 VCL	2.54e-05	59	154	5	M15411
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	ATR NBN POLA2 FANCB UBA1 MTOR RPA1 TOP2A	6.77e-05	230	154	8	M11563
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	CASP8AP2 ATR COPG2 FANCB LRPPRC MDN1 MTOR SUV39H1 SNX27 TAF1 TAF6 EDRF1	1.02e-05	361	150	12	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAT1A CFAP43 SLC9C2 UMODL1 TEKT1 CFAP61 TOP2A CFAP99	4.60e-07	198	154	8	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular\|TCGA-Stomach / Sample_Type by Project: Shred V9	SOX9 FBXW10B ATR ERCC6L STK31 LRPPRC TOP2A	5.34e-07	138	154	7	93497c0a5d5e54006653b2dedc7a7041e1a613e6
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAT1A NRG2 CFAP43 SLC9C2 PTPRT TEKT1 CFAP61	2.93e-06	178	154	7	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 METRNL FPR3 C1QC RAB39A	3.04e-06	179	154	7	dc03b9045510eb1bb934329646bb92dd06890ce9
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 METRNL FPR3 C1QC RAB39A	3.04e-06	179	154	7	330c1326ba93bb8f32559ee1cc40e357cc44ad8d
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP43 EFHB SLC9C2 PTPRT TEKT1 CFAP61 CFAP99	4.36e-06	189	154	7	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)\|Adult / Lineage, Cell type, age group and donor	DOCK2 PIK3AP1 MYO9B METRNL FPR3 C1QC RAB39A	5.00e-06	193	154	7	31c0978ba78c9516d498aec0798902e57555e557
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FAT4 EDAR UNC5C MACF1 FGFR4 CHST2 TMEM178B	5.17e-06	194	154	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	facs-Bladder-nan-3m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA COPG1 UBA1 PTPRA GLG1 MACF1 CAPRIN1	5.53e-06	196	154	7	44f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell	facs-Bladder-nan-3m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA COPG1 UBA1 PTPRA GLG1 MACF1 CAPRIN1	5.53e-06	196	154	7	c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCell	Control-NK\|Control / Disease condition and Cell class	PIK3AP1 METRNL GNLY B3GNT7 ADAM8 MACF1 CHST2	6.11e-06	199	154	7	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP43 EFHB SLC9C2 PTPRT TEKT1 CFAP61 CFAP99	6.31e-06	200	154	7	926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFAP43 EFHB SLC9C2 PTPRT TEKT1 CFAP61 CFAP99	6.31e-06	200	154	7	06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 FAM83F UMODL1 PRELID2 TTL RINL	1.61e-05	154	154	6	66c93733116e31b65dfb4b0b00de5c39d19cdb84
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 EFHB SLC9C2 CFAP61 CFAP99	1.67e-05	155	154	6	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 EFHB SLC9C2 CFAP61 CFAP99	1.67e-05	155	154	6	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	FLU-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	USP18 GNLY IFIH1 CPNE1 DDX60L PLXNA1	1.93e-05	159	154	6	97c8e16a7ac10ebba96daee97f9fb1d4a404f23b
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD1 SYDE2 UNC5C FAM83D CHST7 ARHGEF6	1.93e-05	159	154	6	0dccc4275b9b4f8554dd556da7218e130bff8fd1
ToppCell	FLU-Healthy-1\|FLU / Virus stimulation, Condition and Cluster	USP18 GNLY IFIH1 CPNE1 DDX60L PLXNA1	1.93e-05	159	154	6	fe2a9f79b058e89214256e736f6e266830cdfa28
ToppCell	droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK2 ATR ATP8A2 NCBP3 PIAS4 PRELID2	2.38e-05	165	154	6	8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 FBXW10 FANCB GIMAP8 RPUSD2 TEKT1	2.91e-05	171	154	6	c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRG1 FBXW10 FANCB GIMAP8 RPUSD2 TEKT1	2.91e-05	171	154	6	55b194a9bf4d3e4b5d96e0d1298424359c441cbb
ToppCell	PCW_13-14-Epithelial-Epithelial_ciliated\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MAT1A EFHB PTPRT TEKT1 CFAP61 CFAP99	3.31e-05	175	154	6	b1369d2b74f461e6822d0c33e9b50fe0dfbceb54
ToppCell	PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MAT1A EFHB PTPRT TEKT1 CFAP61 CFAP99	3.31e-05	175	154	6	c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 FPR3 C1QC RAB39A	3.53e-05	177	154	6	cdad5a2f672a7f07c05669bfcaf1ec74defd3de7
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 FPR3 C1QC RAB39A	3.53e-05	177	154	6	991ae76bb615392d84aeb89886148fa42c1c649c
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX9 CARMIL3 NRG2 PTPRT FGFR4 CFAP61	3.65e-05	178	154	6	f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 METRNL FPR3 RAB39A	3.88e-05	180	154	6	97241f62ee133dcb0d4855ffda5dd1349de9f7b2
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 METRNL FPR3 RAB39A	3.88e-05	180	154	6	41896546cd1cc458e08c0d4e19aa4860e5d4fcd6
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP43 SLC9C2 PTPRT TEKT1 CFAP61 CFAP99	4.00e-05	181	154	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FAT4 COL25A1 UNC5C MACF1 FGFR4 CHST2	4.13e-05	182	154	6	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	MAT1A CFAP43 SLC9C2 PTPRT TEKT1 CFAP61	4.13e-05	182	154	6	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 METRNL FPR3 RAB39A	4.13e-05	182	154	6	d5d6bc16458bc665e7ad6669040d79f73f640044
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 PIK3AP1 NRG1 METRNL FPR3 RAB39A	4.13e-05	182	154	6	0b59ead4bb4486c7ec2ee90b94ee3a09905612c5
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	PIK3AP1 METRNL CARMIL3 GNLY MACF1 VCL	4.25e-05	183	154	6	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PSMC2 FAM83D CHST7 PLXNA1 TOP2A ARHGEF6	4.39e-05	184	154	6	7f8488dbb1ee41372cdbcd34a2e14b377218bf0f
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PIK3AP1 USP18 NBN IFIH1 DDX60L PKN3	4.52e-05	185	154	6	f30fb9d75cdb757b206312992aaf7485bc900f96
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	CFAP43 SLC9C2 PTPRT TEKT1 CFAP61 CFAP99	4.52e-05	185	154	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	COVID-19_Convalescent-PLT_4\|World / Disease Group and Platelet Clusters	KLHL28 ARID4B EXOSC2 BICD1 ORC5 CHST7	4.66e-05	186	154	6	5954a1e3ffafb33f2a9bc87af3343f304fda4c92
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	UBR1 CASP8AP2 ARID4B KLHL20 EDAR TAF1	4.66e-05	186	154	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP43 SLC9C2 PTPRT TEKT1 CFAP61 CFAP99	4.80e-05	187	154	6	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	CFAP43 SLC9C2 PTPRT TEKT1 CFAP61 CFAP99	4.94e-05	188	154	6	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	CFAP43 EFHB SLC9C2 PTPRT TEKT1 CFAP61	4.94e-05	188	154	6	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP43 EFHB SLC9C2 PTPRT TEKT1 CFAP61	4.94e-05	188	154	6	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL25A1 UNC5C MACF1 FGFR4 CHST2 VCL	5.09e-05	189	154	6	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 PIK3AP1 MYO9B FPR3 C1QC RAB39A	5.24e-05	190	154	6	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	facs-GAT-Fat-3m\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA UBA1 SVIL CPNE1 CAPRIN1 VCL	5.24e-05	190	154	6	1d92be1b41cff59e834a9d28868f554bd1f3e471
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 PIK3AP1 MYO9B FPR3 C1QC RAB39A	5.40e-05	191	154	6	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	UBR1 VPS13C NBAS GLG1 MACF1 EDRF1	5.40e-05	191	154	6	9454f642c3621370fa23640b631301346b300950
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 NRG1 PTPRT PRELID2 ADAMTS20 PLXNA1	5.55e-05	192	154	6	63d1b3efe93e5ff939278ebe40bacb38218ea09b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 COL25A1 PTPRT PRELID2 ADAMTS20 PLXNA1	5.55e-05	192	154	6	342842378c20267c5044bdd622515e8b9f895623
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 COL25A1 PTPRT PRELID2 ADAMTS20 PLXNA1	5.55e-05	192	154	6	bd3fa6c8fcb618db64d11f25cabaf08608957c35
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK2 PIK3AP1 MYO9B METRNL FPR3 ADAM8	5.88e-05	194	154	6	3043f6230fa723037c8cf7123f611ae847b39fd4
ToppCell	ILEUM-non-inflamed-(6)_ILC1\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PIK3AP1 METRNL GNLY B3GNT7 ADAM8 PTP4A1	5.88e-05	194	154	6	396f9a6b370721d425cbe335dbeea5f9514c92dc
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK2 PIK3AP1 MYO9B METRNL ADAM8 ZNF106	6.05e-05	195	154	6	d53585715c7f5827c4f5a6db11cb31857ee9d4f0
ToppCell	Immune-alveolar_macrophage_(MARCO_positive)\|World / Lineage, Cell type, age group and donor	DOCK2 PIK3AP1 MYO9B FPR3 C1QC DDX60L	6.05e-05	195	154	6	f92114ef995e690a3bedc62c89c5fd6773d0d9f7
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FAT4 EDAR UNC5C MACF1 CHST2 TMEM178B	6.05e-05	195	154	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	MAT1A EFHB UMODL1 TEKT1 CFAP61 CFAP99	6.05e-05	195	154	6	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 PIK3AP1 MYO9B FPR3 C1QC RAB39A	6.05e-05	195	154	6	34a9462f4e843f3065cc58c17ad71c1b5b836ae1
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD1 COL25A1 UNC5C CHST7 ARHGEF6	6.11e-05	120	154	5	a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a
ToppCell	T_cells-CD56_dim_CD16+_NK_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	PIK3AP1 METRNL GNLY ADAM8 CHST2 VCL	6.23e-05	196	154	6	07b557b8530c19ca5b31ad2eac00c36ef1939266
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FBXW10B FBXW10 ERCC6L TEKT1 TOP2A CFAP99	6.40e-05	197	154	6	861e8df9bd74dc5e17bafdc1fb3fef546753c73a
ToppCell	COVID-19\|World / Condition, Lineage and Cell class	USP18 GNLY ADAM8 IFIH1 GIMAP8 MACF1	6.40e-05	197	154	6	228f641d79282cc3dc51b95a1f4b0cccfc200735
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	USP18 ARID4B METRNL VPS13C IFIH1 DDX60L	6.40e-05	197	154	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	severe-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PIK3AP1 METRNL GNLY B3GNT7 ADAM8 CHST2	6.59e-05	198	154	6	6ef22f33b43e9adceea11738e3cba0e8b59b4ec6
ToppCell	COVID-19_Severe-NK\|COVID-19_Severe / Disease condition and Cell class	PIK3AP1 METRNL GNLY B3GNT7 ADAM8 CHST2	6.59e-05	198	154	6	742c4d6016cfa48444a5919a885ab8d02cad7e18
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 PIK3AP1 ARID4B VPS13C GIMAP8 RAB39A	6.59e-05	198	154	6	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 PIK3AP1 MYO9B FPR3 C1QC RAB39A	6.59e-05	198	154	6	96883ad8e189a46ed5b7eaafc0543e53682d26ed
ToppCell	mild-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PIK3AP1 METRNL GNLY B3GNT7 ADAM8 CHST2	6.59e-05	198	154	6	1d20fc9948965de52a98f758035edfdd12cafc5f
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	USP18 ARID4B METRNL VPS13C IFIH1 DDX60L	6.59e-05	198	154	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 PIK3AP1 ARID4B VPS13C GIMAP8 RAB39A	6.59e-05	198	154	6	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	390C-Lymphocytic-NK_cells\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PIK3AP1 METRNL GNLY B3GNT7 ADAM8 CHST2	6.59e-05	198	154	6	623e5ada1a54cd42c32a1519b84dbe782384ee0c
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 PIK3AP1 FPR3 GIMAP8 C1QC RAB39A	6.59e-05	198	154	6	0b928a829844f49f4d47e88908af192cb919011f
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 PIK3AP1 ARID4B VPS13C GIMAP8 RAB39A	6.59e-05	198	154	6	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	USP18 ARID4B METRNL VPS13C IFIH1 DDX60L	6.59e-05	198	154	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 PIK3AP1 FPR3 GIMAP8 C1QC RAB39A	6.77e-05	199	154	6	6ce7612ee2ae211eb0f73391e96089ad5431c537
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 PIK3AP1 FPR3 GIMAP8 C1QC RAB39A	6.96e-05	200	154	6	f3dc07a7cc8cf041da8fe610d21af595818cf2d8
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TDRD9 MAT1A EFHB SLC9C2 TEKT1 CFAP99	6.96e-05	200	154	6	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP18 ARID4B VPS13C IFIH1 MACF1 DDX60L	6.96e-05	200	154	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 PIK3AP1 MYO9B METRNL FPR3 KSR1	6.96e-05	200	154	6	5432bdf495431cd26f6e4cd585100f3652588913
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAT1A CFAP43 SLC9C2 TEKT1 CFAP61 CFAP99	6.96e-05	200	154	6	73ac1cf40ddd764be1100cbfaaa29563665457d8
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 PIK3AP1 MYO9B FPR3 TTL RAB39A	6.96e-05	200	154	6	78d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell	COVID-19_Mild-NK\|COVID-19_Mild / Disease condition and Cell class	PIK3AP1 METRNL GNLY B3GNT7 ADAM8 CHST2	6.96e-05	200	154	6	b586b0f1127293c2f8529be16b24229359041da2
ToppCell	Bronchial-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 PIK3AP1 MYO9B FPR3 C1QC DDX60L	6.96e-05	200	154	6	2f5b71e55c2de0e77fdae6667eb57f333acc6cd1
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	SOX9 ERCC6L FANCB FAM83D TOP2A PKN3	6.96e-05	200	154	6	0bba93f1271dac704dddcdea8cb0f84a7ac6f42a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	SOX9 ERCC6L FANCB FAM83D TOP2A PKN3	6.96e-05	200	154	6	c9479452ab8c51139522383f745f02171ebbd7e2
ToppCell	TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4\|TCGA-Cervix / Sample_Type by Project: Shred V9	CFAP43 SLC9C2 TEKT1 CFAP61 CFAP99	1.35e-04	142	154	5	369f2e51e0283a4de70e6c7a3b95672c0838f205
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 IGFBP1 CFAP61 CFAP99	1.64e-04	148	154	5	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 IGFBP1 CFAP61 CFAP99	1.64e-04	148	154	5	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	WDR64 ATP8A2 ADAM29 PTPRT ADAMTS20	1.75e-04	150	154	5	0205318a870e091add66ee4305747dda9f51510d
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERCC6L GNLY ADAM8 TAF1L TOP2A	1.80e-04	151	154	5	535872e231ac0ee7b4fc4d02a260752cbbf50a2b
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 EFHB CFAP61 CFAP99	1.80e-04	151	154	5	81cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 EFHB CFAP61 CFAP99	1.80e-04	151	154	5	9cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD1 FAT4 COL25A1 PTPRT CHST7	1.86e-04	152	154	5	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 EFHB CFAP61 CFAP99	1.97e-04	154	154	5	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAT1A CFAP43 EFHB CFAP61 CFAP99	1.97e-04	154	154	5	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|GI_small-bowel / Manually curated celltypes from each tissue	PIK3AP1 METRNL NRG2 GNLY FAM83F	2.03e-04	155	154	5	1c67f58ed79331addbc012dab0cb09a7f350aedb
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 UMODL1 PRELID2 TTL RPUSD2	2.16e-04	157	154	5	b527e88382c8d21188a0f222b3302523e8816dfc
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	METRNL GNLY UMODL1 CHST2 VCL	2.22e-04	158	154	5	1bf692f1e85f677cd62805437b7a59cfaf3b0449
ToppCell	356C-Fibroblasts-Fibroblast-D-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DOCK2 SWT1 EIF3CL GIMAP8 SLC25A15	2.29e-04	159	154	5	299e2162a82e31196d7f3a110c2db622349edfff
Disease	Adenocarcinoma of lung (disorder)	TRPM6 ATR INSRR ARHGAP35 TTF1 FGFR4 TAF1L TOP2A	1.01e-05	206	148	8	C0152013
Disease	Intellectual Disability	SOX9 HDAC4 CAMK2A ATP8A2 MTOR ALG14 SNX27 MACF1 TAF1 TAF2 TAF6	1.70e-05	447	148	11	C3714756
Disease	monocyte percentage of leukocytes	PIK3AP1 POLR1A ARID4B METRNL CYP26A1 B3GNT7 NCBP3 IFIH1 KSR1 GLG1 SLC22A3 NEURL4	3.32e-04	731	148	12	EFO_0007989
Disease	Aicardi-Goutieres Syndrome 2	USP18 IFIH1	3.70e-04	6	148	2	C3489724
Disease	Lissencephaly	TMTC3 MACF1	3.70e-04	6	148	2	C0266463
Disease	AICARDI-GOUTIERES SYNDROME 1	USP18 IFIH1	3.70e-04	6	148	2	C0796126
Disease	Pseudo-TORCH syndrome	USP18 IFIH1	5.16e-04	7	148	2	C3489725
Disease	Large cell carcinoma of lung	TRPM6 ATR MTOR	5.51e-04	32	148	3	C0345958
Disease	amino acid measurement	FAT4 SPRED2 HDAC4 CAMK2G ORC5 NBAS GUCY2C FBXO31 CYP26C1 TTL TEKT1	6.48e-04	678	148	11	EFO_0005134
Disease	AICARDI-GOUTIERES SYNDROME	USP18 IFIH1	6.86e-04	8	148	2	C0393591
Disease	Autoinflammatory disorder	USP18 COPA IFIH1	7.19e-04	35	148	3	C3860213
Disease	orthostatic hypotension	PIK3AP1 GUCY2C	8.79e-04	9	148	2	EFO_0005252
Disease	Adenoid Cystic Carcinoma	ARID4B INSRR FGFR4 TOP2A	1.64e-03	100	148	4	C0010606
Disease	pallidum volume change measurement	EFHB TRAPPC9	1.88e-03	13	148	2	EFO_0021494
Disease	episodic memory	TRPM6 METRNL NBAS	2.28e-03	52	148	3	EFO_0004333
Disease	mean reticulocyte volume	POLR1A SPRED2 ATR MYO9B PTPRA TMTC3 MTOR SLC22A3 CPNE1 RPA1 TRAPPC9	2.39e-03	799	148	11	EFO_0010701
Disease	granulysin measurement	GNLY CPNE1	2.51e-03	15	148	2	EFO_0008144
Disease	head and neck squamous cell carcinoma (is_implicated_in)	FANCB FGFR4	2.51e-03	15	148	2	DOID:5520 (is_implicated_in)
Disease	Rhabdomyosarcoma	NBN FGFR4	2.51e-03	15	148	2	C0035412
Disease	Metastatic melanoma	GUCY2C MTOR TAF1	2.54e-03	54	148	3	C0278883
Disease	IGF-1 measurement	VPS13C CYP26A1 LRPPRC SLC22A3 CYP26C1 DDX60L CFAP61 TOP2A	3.32e-03	488	148	8	EFO_0004627
Disease	uric acid measurement	GAD1 NRG1 FAT4 POLR1A SWT1 INSRR POLA2 SLC22A3 RPA1	3.76e-03	610	148	9	EFO_0004761
Disease	vital capacity	NRG1 SPRED2 METRNL CAMK2G B3GNT7 INO80 STK31 ZNF106 EDAR WDR41 FGFR4 TMEM178B PLXNA1 ARHGEF6	3.81e-03	1236	148	14	EFO_0004312
Disease	emphysema pattern measurement	SVIL TRAPPC9	4.04e-03	19	148	2	EFO_0005850
Disease	testosterone measurement	TRPM6 UBR1 POLR1A ERCC6L MYO9B METRNL POR COL25A1 PTP4A1 SLC22A3 CYP26C1 MACF1 ARHGEF6 PKN3	5.00e-03	1275	148	14	EFO_0004908

Protein segments in the cluster

Peptide	Gene	Start	Entry
LLGDIAKRVYEVISV	UMODL1	246	Q5DID0
ESCLSIVREKLYKGI	TTF1	706	Q15361
LIVVDDVRKSVHLYC	ADAM29	256	Q9UKF5
ELLGKVVCVDYISLD	ARID4B	171	Q4LE39
IAKCGILCIRDVYTL	CFAP43	656	Q8NDM7
VGCCKEILRTVYKAV	CFAP61	116	Q8NHU2
VCKGDIIYVTRVEEG	ARHGEF6	181	Q15052
NGLEILECKYRVAVT	BICD1	411	Q96G01
LECKYRVAVTEVIDL	BICD1	416	Q96G01
VDSDKVIIITCDRGY	CXorf66	336	Q5JRM2
LRVISACADGKIRIY	FBXW10	626	Q5XX13
VLCLQYDERVIITGS	BTRC	346	Q9Y297
YIVSVRCEEKTVGRL	FAT4	1666	Q6V0I7
LYVIVECAAKGNLRE	FGFR4	546	P22455
KVIIVYVESICRVET	ALG14	166	Q96F25
AVVLVTLAGIIVYRK	ADAM8	666	P78325
ETTVYVIVRCKLDDR	PIK3AP1	191	Q6ZUJ8
LKIYSGDLVVCETVI	PIK3AP1	246	Q6ZUJ8
VANRPLKCIVEETYI	CASP8AP2	1781	Q9UKL3
CGTTYKVLKEIVERV	CAPRIN1	226	Q14444
TYVVVTVCLKAGLET	ATP8A2	1006	Q9NTI2
RDVYCRLKGVGQVVE	ADAMTS20	1496	P59510
LTRDIYELIKKGEIC	RAB39A	171	Q14964
ILKRTECQFLYEVRG	GUCY2C	971	P25092
VYRLICKGTIEERIL	INO80	1221	Q9ULG1
PVVYCVRLAKALVDD	INTS15	141	Q96N11
EELYQKRVLTITGIC	NRG1	236	Q02297
LVVKDRTISFLGCVV	OR5D18	86	Q8NGL1
LRVISACADGKIRIY	FBXW10B	626	O95170
FVLEVLSGCLEYRKL	CFAP99	46	D6REC4
LSGCLEYRKLLTVVV	CFAP99	51	D6REC4
ELALRSYVLVESVCK	MDN1	296	Q9NU22
ARLAVGCVVELVFKV	HDAC4	771	P56524
TYCGVQLVKERERTL	HHATL	476	Q9HCP6
VVTVDAKIYERCELA	SPACA5	16	Q96QH8
ICAVVVEYETKAGRI	POR	471	P16435
CRLVLSYVLEGLKSV	EDRF1	601	Q3B7T1
VVCREYELERPKSVI	KIAA1109	946	Q2LD37
RKKILDVYANVCGVV	EDAR	326	Q9UNE0
IITVCYGIIAAKIHR	FPR3	216	P25089
YCKDLRLGSEVLEQV	CARMIL3	221	Q8ND23
KVLRESDVGVVVYVA	DDX60L	781	Q5H9U9
EQILVDCRDTLKYGV	GAD1	166	Q99259
LRKLEITGVSCRDVY	FBXO31	121	Q5XUX0
RVGKVLCSPVESEYI	PLXNA1	901	Q9UIW2
CRIELYRVVESLAKA	IGFBP1	176	P08833
QEIRTLEAKLVRYIC	KSR1	71	Q8IVT5
CDDIRVNVVYGLIVI	OR51E1	191	Q8TCB6
LSVVAVVSCLYLGVK	COL25A1	41	Q9BXS0
EICRKQGVAVYILLD	FAM83D	181	Q9H4H8
LYQKRVLTITGICVA	NRG2	401	O14511
ELGRDYRTCLTIVQK	GNLY	61	P22749
PKVRLETIYICGVDE	NCBP3	121	Q53F19
LGVCYIVVKVSLLVV	MARCHF6	366	O60337
VKAGLCRRVLVQVSY	MAT1A	306	Q00266
FRECLTEVIRYLGVL	HEYL	121	Q9NQ87
VSEILEKVTCERRYI	LRPPRC	321	P42704
KEVEQVYLRCAAGAV	METRNL	66	Q641Q3
RIFGEVAVATVICKD	PRSS37	186	A4D1T9
LICVKALKTRYIGEV	EXOSC2	66	Q13868
LVYEARCDVTLTLKE	NBAS	891	A2RRP1
CKIDIESGQRYLEVI	MACF1	2641	Q9UPN3
GDLVQVCYDLERIKL	MIB1	336	Q86YT6
VTNLVEVGRVKCVRY	PTPRT	986	O14522
KDRYVVCGRVFLSLE	FANCB	611	Q8NB91
LVDIIGICKSYEDAT	RPA1	316	P27694
ANLCVLLYRSGVKVV	C1QC	176	P02747
SELEGQVISCLKLRY	GLG1	961	Q92896
CAIIERVQRYLEEKG	EIF3CL	481	B5ME19
YVRNICKALLDVLGI	ATR	371	Q13535
VEIAYVGATILDVCK	FBH1	706	Q8NFZ0
ELCDVVLVVGAKKIY	KLHL20	66	Q9Y2M5
ICVLDQKVYVIGGIA	KLHL28	326	Q9NXS3
DIISIESCKEYLLGV	C2CD3	1306	Q4AC94
ERKYCVELLNSILEV	DOCK2	881	Q92608
ICREYIVGLSVETER	COPA	1056	P53621
CVFREKETLNIVLVG	GIMAP8	431	Q8ND71
LDIKECNIVIRYGLV	IFIH1	796	Q9BYX4
AALGRLRYVDCVVKE	CYP26C1	361	Q6V0L0
FEYKRAIVDCIISIV	COPG2	411	Q9UBF2
IKYRRLGEEATVLCV	INSRR	851	P14616
KVIPVGYRVATCLTE	EFHB	266	Q8N7U6
EQLKYIGCVIKETLR	CYP26A1	351	O43174
FEYKRAIVDCIISII	COPG1	411	Q9Y678
RGDVYLLVVVKSVIT	B3GNT7	131	Q8NFL0
IYTTICRIGTVIKDN	NBEAP1	76	P0C6P0
KLGRKVETITIIYDC	SEC14L2	141	O76054
CYVIVTEIVGSKQRR	SLC22A3	226	O75751
VIGEDAACIAYIRLT	CAMK2G	501	Q13555
AVVDLYGKCTQITVL	NEURL4	191	Q96JN8
IRVKICRVETEYSFL	CPNE1	261	Q99829
KENVVVYRLITCGTV	ERCC6L	576	Q2NKX8
GNVTKEVIVLYLTLC	KRBA2	221	Q6ZNG9
DVTVLVDYTVRKFCI	PTPRA	371	P18433
IESLYCEKRILEAVG	PKN3	601	Q6P5Z2
DKGQVRKCLDVVEIY	KBTBD12	506	Q3ZCT8
AVLLVRAQEIGYTVC	OR52L2P	101	Q8NGH6
VLICRIVKGYTLADE	MTOR	1211	P42345
LVVSYKVGVCRVDPR	RPUSD2	326	Q8IZ73
IKLVGERYCKTTDVL	MRPS35	191	P82673
CFIRVIGSELVQKYV	PSMC2	236	P35998
EIEKRGCQVVGLYRL	SYDE2	841	Q5VT97
CQLLTDEVSYRIKEI	TAF6	36	P49848
IAALIRKGEIERCTY	TMEM178B	121	H3BS89
TYGIEAALRVIEKEI	POLR1A	1611	O95602
KRELGCRATYIQTIE	SVIL	1506	O95425
LLKIICGVVTIRTVY	SYNJ2	181	O15056
LLGVVEVYRVTKRVE	SYNRG	1171	Q9UMZ2
DVKYVIDFCLTRTLV	TDRD9	456	Q8NDG6
CVGLEKGTLVLIIYE	TEDDM1	96	Q5T9Z0
GVEYVVGRKNCAILI	NBN	21	O60934
KEYVRCETVRKPAVI	TAF1L	1196	Q8IZX4
CETVRKPAVIDAYVR	TAF1L	1201	Q8IZX4
RCETVRKPAVIDAYV	TAF1	1181	P21675
IRIAALEAVVDYTKV	TAF2	886	Q6P1X5
LLGVFYTVCRDLKEL	ORC5	211	O43913
IVRDIKEKLCYVALD	POTEJ	871	P0CG39
ITETCLAYREKRIGI	TEKT1	111	Q969V4
VCIREAVSQVLKGYD	SOX9	71	P48436
EALIEKLVELCVQYG	POLA2	21	Q14181
VVRRCVKVLAGQEYA	CAMK2A	26	Q9UQM7
EYREKLTIGCRQLVE	SWT1	856	Q5T5J6
AVYPVDCIKSRIQVL	SLC25A15	226	Q9Y619
VVVLTKCDEGVERYI	ARHGAP35	196	Q9NRY4
IVDAACKRRVPVYII	FAM83F	181	Q8NEG4
VVQKGIRYDLCIFRT	SUV39H1	236	O43463
AYRKEVVGLVDDRVC	CHST2	266	Q9Y4C5
ALEAECRKYPVVVIK	CHST7	236	Q9NS84
LKIISVEKCLVRYID	STK31	101	Q9BXU1
KVALLLEVCRDVYAG	RINL	426	Q6ZS11
RYERLQKICSIALVG	CTPS2	291	Q9NRF8
GEEATVKAVIACILY	TRPM6	631	Q9BX84
KCLRGTVAAVYDVTL	AGPAT3	216	Q9NRZ7
AVPAVCKTRTVIYEI	PDGFA	91	P04085
DCVPEERRKLIVAYV	TCERG1	1061	O14776
CLVKYLLSTRVDGQV	RNF222	41	A6NCQ9
VRKIIRVCKGILEYL	VCL	131	P18206
RVCKGILEYLTVAEV	VCL	136	P18206
LYGRKVITENVIVDC	GPLD1	196	P80108
IFLKIRECRVVLVEG	UBR1	1666	Q8IWV7
ESTGVIYRKRIAICQ	PRELID2	46	Q8N945
EYLEKVCSIRVIGES	SNX27	241	Q96L92
GERQKDKLVVLECYV	SPRED2	61	Q7Z698
DKLVVLECYVRKDLV	SPRED2	66	Q7Z698
IDAVLDKLYVCASVE	VPS13C	2041	Q709C8
TCRDIVKEVAKIIYI	PSMA3	186	P25788
VVGLVCLELYKVVQG	UBA1	901	P22314
ELCYKVIVTRESGLQ	TTLL12	96	Q14166
VKAVQVVLRICYSDT	PIAS4	186	Q8N2W9
VGCLKKYDTVLDILR	TOP2A	1006	P11388
IIGELSCLLKREIEY	SLC9C2	946	Q5TAH2
FIIYSIRGDVCDLKV	TPTE2	401	Q6XPS3
GVIELEACIKAVRVL	TRAPPC9	341	Q96Q05
ALYTIRVKDSLICVD	USP18	166	Q9UMW8
LKEITLIVGVVTACY	TMTC3	6	Q6ZXV5
KLYAELCQGIVDIAI	TTL	341	Q8NG68
DVALYVGIVIAVIVC	UNC5C	376	O95185
ELKKYGVTTIVRVCE	PTP4A1	36	Q93096
KLLVVGSYDCTISVR	ZNF106	1671	Q9H2Y7
CVVAAVGKELIIFRL	WDR41	186	Q9HAD4
ITGCDYLLQLKRIVA	WDR64	166	B1ANS9
RLDGTKCYVLVEVKE	MYO9B	56	Q13459